Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +0.75% | -10.14% | +31.67% |
May. 15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.67% | 81.33M | |
+9.84% | 115B | |
+11.89% | 106B | |
-2.94% | 21.96B | |
-14.18% | 21.87B | |
-5.29% | 19.21B | |
-3.20% | 18.08B | |
-38.57% | 17.71B | |
+6.63% | 14.32B | |
+35.81% | 12.42B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Transcript : Passage Bio, Inc. - Special Call